{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:50:46Z","timestamp":1788828646591,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003654","name":"Korea Environmental Industry and Technology Institute","doi-asserted-by":"publisher","award":["2022003310005"],"award-info":[{"award-number":["2022003310005"]}],"id":[{"id":"10.13039\/501100003654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003562","name":"Ministry of Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.fct.2023.113781","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T15:30:02Z","timestamp":1681313402000},"page":"113781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Investigating fatty liver disease-associated adverse outcome pathways of perfluorooctane sulfonate using a systems toxicology approach"],"prefix":"10.1016","volume":"176","author":[{"given":"Moosoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-6197","authenticated-orcid":false,"given":"Yong Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2023.113781_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.reprotox.2011.11.005","article-title":"Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues","volume":"33","author":"Abbott","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/tx500345j","article-title":"Defining molecular initiating events in the adverse outcome pathway framework for risk assessment","volume":"27","author":"Allen","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/acs.chemrestox.9b00136","article-title":"Quantitative predictions for molecular initiating events using three-dimensional quantitative structure\u2013activity relationships","volume":"33","author":"Allen","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib4","first-page":"1","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.fct.2023.113781_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cotox.2018.03.004","article-title":"The adverse outcome oathway: a multifaceted framework supporting 21st Century Toxicology","volume":"9","author":"Ankley","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.fct.2023.113781_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.envpol.2019.01.064","article-title":"Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines","volume":"247","author":"Bassler","year":"2019","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.fct.2023.113781_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integrated Environ. Assess. Manag."},{"key":"10.1016\/j.fct.2023.113781_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/jme.1.01909","article-title":"Defining high-fat-diet rat models: metabolic and molecular effects of different fat types","volume":"36","author":"Buettner","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.fct.2023.113781_bib10","doi-asserted-by":"crossref","DOI":"10.1289\/EHP10092","article-title":"Exposure to per- and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis","volume":"130","author":"Costello","year":"2022","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.fct.2023.113781_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhazmat.2015.06.031","article-title":"Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ","volume":"299","author":"Cui","year":"2015","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.fct.2023.113781_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.scitotenv.2018.03.024","article-title":"Per- and polyfluoroalkyl substances (PFASs) in water, soil and plants in wetlands and agricultural areas in Kampala, Uganda","volume":"631\u2013632","author":"Dalahmeh","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.fct.2023.113781_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tox.2016.12.007","article-title":"Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis","volume":"378","author":"Das","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2023.113781_bib14","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.3390\/ijms21113858","article-title":"Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease","volume":"21","author":"de Gregorio","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/etc.4935","article-title":"PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding","volume":"40","author":"De Silva","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.fct.2023.113781_bib16","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1159\/000358720","article-title":"SREBP-1c gene silencing can decrease lipid deposits in bovine hepatocytes cultured in vitro","volume":"33","author":"Deng","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.fct.2023.113781_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7150\/ijbs.19370","article-title":"Emerging roles of SIRT1 in fatty liver diseases","volume":"13","author":"Ding","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib18","first-page":"E321","article-title":"Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification","volume":"274","author":"Diraison","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.fct.2023.113781_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.fct.2023.113781_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.envint.2018.12.026","article-title":"Perfluoroalkyl substances and risk of type II diabetes: a prospective nested case-control study","volume":"123","author":"Donat-Vargas","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.fct.2023.113781_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2023.113781_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.116840","article-title":"Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression","volume":"278","author":"Duan","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.fct.2023.113781_bib23","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.0812931106","article-title":"SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats","volume":"106","author":"Erion","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.fct.2023.113781_bib24","first-page":"72","article-title":"SREBP-1c transcription factor and lipid homeostasis: clinical perspective","volume":"68","author":"Ferr\u00e9","year":"2007","journal-title":"Horm. Res."},{"key":"10.1016\/j.fct.2023.113781_bib25","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1073\/pnas.96.22.12737","article-title":"Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes","volume":"96","author":"Foretz","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.fct.2023.113781_bib26","article-title":"Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort","volume":"4","author":"Goodrich","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.fct.2023.113781_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. Roy. Soc. Med."},{"key":"10.1016\/j.fct.2023.113781_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0220001","article-title":"Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences","volume":"22","author":"Holden","year":"1999","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.fct.2023.113781_bib29","series-title":"Alternative Methods for Regulatory Toxicology: A State-Of-The-Art Review","author":"Goumenou","year":"2014"},{"key":"10.1016\/j.fct.2023.113781_bib30","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.fct.2023.113781_bib31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ijms20051209","article-title":"In silico molecular docking and in vivo validation with Caenorhabditis elegans to discover molecular initiating events in adverse outcome pathway framework: case study on endocrine-disrupting chemicals with estrogen and androgen receptors","volume":"20","author":"Jeong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.scitotenv.2018.04.380","article-title":"A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs)","volume":"636","author":"Jian","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.fct.2023.113781_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/bioinformatics\/btab750","article-title":"AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development","volume":"38","author":"Jornod","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.fct.2023.113781_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.fct.2023.113781_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yrtph.2016.01.007","article-title":"Adverse outcome pathways: from research to regulation scientific workshop report","volume":"76","author":"Kleinstreuer","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2023.113781_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031812","article-title":"Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass","volume":"7","author":"Knebel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2023.113781_bib37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12020-014-0465-x","article-title":"Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients","volume":"49","author":"Mariani","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.fct.2023.113781_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115991","article-title":"Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes","volume":"442","author":"Marques","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2023.113781_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2017.11.008","article-title":"Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels","volume":"111","author":"Mora","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.fct.2023.113781_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.reprotox.2022.01.004","article-title":"Using adverse outcome pathways to contextualise (Q)SAR predictions for reproductive toxicity \u2013 a case study with aromatase inhibition","volume":"108","author":"Myden","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib41","first-page":"631","article-title":"Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"16","author":"Nakamuta","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.fct.2023.113781_bib42","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1021\/jf104943p","article-title":"Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in The Netherlands","volume":"59","author":"Noorlander","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.fct.2023.113781_bib43","series-title":"Revised Guidance Document on Developing and Assessing Adverse Outcome Pathways","year":"2013"},{"key":"10.1016\/j.fct.2023.113781_bib44","series-title":"Users's Handbook Supplement to the Guidance Document for Developing and Assessing Adverse Outcome Pathways","year":"2018"},{"key":"10.1016\/j.fct.2023.113781_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/es802216n","article-title":"A first global production, emission, and environmental inventory for perfluorooctane sulfonate","volume":"43","author":"Paul","year":"2009","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.fct.2023.113781_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","article-title":"Accumulation of perfluoroalkyl substances in human tissues","volume":"59","author":"Perez","year":"2013","journal-title":"Environ. Int."},{"key":"10.1016\/j.fct.2023.113781_bib47","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pinero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fct.2023.113781_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.taap.2018.02.006","article-title":"AOP-DB: a database resource for the exploration of adverse outcome pathways through integrated association networks","volume":"343","author":"Pittman","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2023.113781_bib49","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2023.113781_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.fct.2023.113781_bib51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.intimp.2010.08.009","article-title":"Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice","volume":"10","author":"Qazi","year":"2010","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.fct.2023.113781_bib52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jat.4258","article-title":"PFOS facilitates liver inflammation and steatosis: an involvement of NLRP3 inflammasome-mediated hepatocyte pyroptosis","volume":"42","author":"Qin","year":"2022","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.fct.2023.113781_bib53","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2023.113781_bib54","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0192623308318208","article-title":"Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid","volume":"36","author":"Rosen","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.fct.2023.113781_bib55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"key":"10.1016\/j.fct.2023.113781_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4939-7899-1_2","article-title":"The OECD QSAR toolbox starts tts second decade","volume":"1800","author":"Schultz","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.fct.2023.113781_bib57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","article-title":"Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"76","author":"Sen","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.113781_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/toxics9030059","article-title":"Novel QSAR models for molecular initiating event modeling in two intersecting adverse outcome pathways based pulmonary fibrosis prediction for biocidal mixtures","volume":"9","author":"Seo","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.fct.2023.113781_bib59","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.envpol.2015.10.050","article-title":"Perfluoroalkyl substances (PFAS) in river and ground\/drinking water of the Ganges River basin: emissions and implications for human exposure","volume":"208","author":"Sharma","year":"2016","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.fct.2023.113781_bib60","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/b603600g","article-title":"The type I fatty acid and polyketide synthases: a tale of two megasynthases","volume":"24","author":"Smith","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.fct.2023.113781_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100138","article-title":"Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis","volume":"12","author":"Sozen","year":"2021","journal-title":"Metabol. Open."},{"key":"10.1016\/j.fct.2023.113781_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74617-5","article-title":"HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse","volume":"10","author":"Tsuru","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2023.113781_bib63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","article-title":"Adverse outcome pathway (AOP) development I: strategies and principles","volume":"142","author":"Villeneuve","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib64","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1101\/gad.1901210","article-title":"Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP","volume":"24","author":"Walker","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.fct.2023.113781_bib65","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbagen.2012.03.010","article-title":"PFOS-induced hepatic steatosis, the mechanistic actions on beta-oxidation and lipid transport","volume":"1820","author":"Wan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2023.113781_bib66","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1021\/es900464a","article-title":"Perspectives on the inclusion of perfluorooctane sulfonate into the Stockholm convention on persistent organic pollutants","volume":"43","author":"Wang","year":"2009","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.fct.2023.113781_bib67","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7150\/ijbs.6.682","article-title":"Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition","volume":"6","author":"Wang","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfn166","article-title":"Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths","volume":"106","author":"Wolf","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib69","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.fct.2023.113781_bib70","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1210\/en.2009-1013","article-title":"Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+\/- mice: a role of lipid mobilization and inflammation","volume":"151","author":"Xu","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fct.2023.113781_bib71","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2023.113781_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152365","article-title":"Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice","volume":"431","author":"Zhang","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2023.113781_bib73","doi-asserted-by":"crossref","first-page":"153932","DOI":"10.1016\/j.scitotenv.2022.153932","article-title":"Associating diethylhexyl phthalate to gestational diabetes mellitus via adverse outcome pathways using a network-based approach","volume":"824","author":"Zhang","year":"2022","journal-title":"Sci. Total Environ."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:09:40Z","timestamp":1736345380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691523001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":73,"alternative-id":["S0278691523001837"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2023.113781","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating fatty liver disease-associated adverse outcome pathways of perfluorooctane sulfonate using a systems toxicology approach","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.113781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113781"}}